The total return over the past 12 months is -80.44% vs. +16.94% for the S&P 500. So far it's up -66.54% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (80.44%) | (73.93%) | N/A | N/A | N/A | N/A |
| Total Return CAGR | (80.44%) | (73.93%) | N/A | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Bone Biologics Corporation (BBLG)
| Year | Start price | End price | BBLG Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.45 | $0.49 | (66.54%) | +14.51% | (81.05%) |
| 2025 | $5.64 | $1.45 | (74.29%) | +17.72% | (92.01%) |
| 2024 | $27.12 | $5.64 | (79.20%) | +24.89% | (104.09%) |
| 2023 | $151.14 | $27.12 | (82.06%) | +26.19% | (108.25%) |
| 2022 | $2,536.92 | $151.14 | (94.04%) | (18.17%) | (75.87%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
